Renewed interest for low‐dose radiation therapy in follicular lymphomas: From biology to clinical applications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renewed interest for low‐dose radiation therapy in follicular lymphomas: From biology to clinical applications

Published:2018-08-26 Issue:5 Volume:36 Page:723-732
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Ciammella Patrizia¹^ORCID,Luminari Stefano²^ORCID,Arcaini Luca³^ORCID,Filippi Andrea Riccardo⁴^ORCID

Affiliation:

1. Radiation Oncology UnitAUSL—IRCCS di Reggio Emilia Reggio Emilia Italy

2. HaematologySanta Maria Nuova Hospital, IRCCS Reggio Emilia Italy

3. Hematology UnitFondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy

4. Radiation Oncology UnitFondazione IRCCS Policlinico S. Matteo Pavia Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2538

Reference85 articles.

1. A revised European‐American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group;Harris NL;Blood,1994

2. Treatment of Follicular Lymphoma

3. Improved Survival of Follicular Lymphoma Patients in the United States

4. Ongoing Improvement in Outcomes for Patients Diagnosed as Having Non-Hodgkin Lymphoma From the 1990s to the Early 21st Century

5. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment;Frontiers in Pharmacology;2024-04-16

2. Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis;Scientific Reports;2021-11-19

3. Low-dose radiotherapy (2×2 g) versus low doses and rituximab in the treatment of marginal zone b-cell lymphoma previously untreated;Leukemia Research;2020-11

4. A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer;Molecular Therapy - Oncolytics;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3